199 related articles for article (PubMed ID: 22749040)
21. Comparative genomic hybridization of low-grade central osteosarcoma.
Tarkkanen M; Böhling T; Gamberi G; Ragazzini P; Benassi MS; Kivioja A; Kallio P; Elomaa I; Picci P; Knuutila S
Mod Pathol; 1998 May; 11(5):421-6. PubMed ID: 9619593
[TBL] [Abstract][Full Text] [Related]
22. Amplification of CDK4 and MDM2 in malignant melanoma.
Muthusamy V; Hobbs C; Nogueira C; Cordon-Cardo C; McKee PH; Chin L; Bosenberg MW
Genes Chromosomes Cancer; 2006 May; 45(5):447-54. PubMed ID: 16419059
[TBL] [Abstract][Full Text] [Related]
23. GNAS mutations are not detected in parosteal and low-grade central osteosarcomas.
Salinas-Souza C; De Andrea C; Bihl M; Kovac M; Pillay N; Forshew T; Gutteridge A; Ye H; Amary MF; Tirabosco R; Toledo SR; Baumhoer D; Flanagan AM
Mod Pathol; 2015 Oct; 28(10):1336-42. PubMed ID: 26248895
[TBL] [Abstract][Full Text] [Related]
24. Parosteal osteosarcoma.
Hang JF; Chen PC
Arch Pathol Lab Med; 2014 May; 138(5):694-9. PubMed ID: 24786129
[TBL] [Abstract][Full Text] [Related]
25. Parosteal osteoliposarcoma: a new bone tumor (from imaging to immunophenotype).
Larousserie F; Chen X; Ding Y; Kreshak J; Cocchi S; Huang X; Niu X; Alberghini M; Vanel D
Eur J Radiol; 2013 Dec; 82(12):2149-53. PubMed ID: 22178310
[TBL] [Abstract][Full Text] [Related]
26. Array-comparative genomic hybridization of central chondrosarcoma: identification of ribosomal protein S6 and cyclin-dependent kinase 4 as candidate target genes for genomic aberrations.
Rozeman LB; Szuhai K; Schrage YM; Rosenberg C; Tanke HJ; Taminiau AH; Cleton-Jansen AM; Bovée JV; Hogendoorn PC
Cancer; 2006 Jul; 107(2):380-8. PubMed ID: 16779802
[TBL] [Abstract][Full Text] [Related]
27. Parosteal osteosarcoma associated with a low-grade component mimicking well-differentiated liposarcoma: a case report.
Sohier P; Rodrigues M; Anract P; Feydy A; Larousserie F
Skeletal Radiol; 2021 Jan; 50(1):243-248. PubMed ID: 32564106
[TBL] [Abstract][Full Text] [Related]
28. Analysis of SAS gene and CDK4 and MDM2 proteins in low-grade osteosarcoma.
Ragazzini P; Gamberi G; Benassi MS; Orlando C; Sestini R; Ferrari C; Molendini L; Sollazzo MR; Merli M; Magagnoli G; Bertoni F; Bohling T; Pazzagli M; Picci P
Cancer Detect Prev; 1999; 23(2):129-36. PubMed ID: 10101594
[TBL] [Abstract][Full Text] [Related]
29. HMGA2 is the partner of MDM2 in well-differentiated and dedifferentiated liposarcomas whereas CDK4 belongs to a distinct inconsistent amplicon.
Italiano A; Bianchini L; Keslair F; Bonnafous S; Cardot-Leccia N; Coindre JM; Dumollard JM; Hofman P; Leroux A; Mainguené C; Peyrottes I; Ranchere-Vince D; Terrier P; Tran A; Gual P; Pedeutour F
Int J Cancer; 2008 May; 122(10):2233-41. PubMed ID: 18214854
[TBL] [Abstract][Full Text] [Related]
30. Extraskeletal osteosarcoma: MDM2 and H3K27me3 analysis of 19 cases suggest disease heterogeneity.
Makise N; Sekimizu M; Kubo T; Wakai S; Watanabe SI; Kato T; Kinoshita T; Hiraoka N; Fukayama M; Kawai A; Ichikawa H; Yoshida A
Histopathology; 2018 Jul; 73(1):147-156. PubMed ID: 29489027
[TBL] [Abstract][Full Text] [Related]
31. Gains and complex rearrangements of the 12q13-15 chromosomal region in ordinary lipomas: the "missing link" between lipomas and liposarcomas?
Italiano A; Cardot N; Dupré F; Monticelli I; Keslair F; Piche M; Mainguené C; Coindre JM; Pedeutour F
Int J Cancer; 2007 Jul; 121(2):308-15. PubMed ID: 17372913
[TBL] [Abstract][Full Text] [Related]
32. SAS is amplified predominantly in surface osteosarcoma.
Noble-Topham SE; Burrow SR; Eppert K; Kandel RA; Meltzer PS; Bell RS; Andrulis IL
J Orthop Res; 1996 Sep; 14(5):700-5. PubMed ID: 8893761
[TBL] [Abstract][Full Text] [Related]
33. Structure of the supernumerary ring and giant rod chromosomes in adipose tissue tumors.
Pedeutour F; Forus A; Coindre JM; Berner JM; Nicolo G; Michiels JF; Terrier P; Ranchere-Vince D; Collin F; Myklebost O; Turc-Carel C
Genes Chromosomes Cancer; 1999 Jan; 24(1):30-41. PubMed ID: 9892106
[TBL] [Abstract][Full Text] [Related]
34. Ring chromosomes and low-grade gene amplification in an atypical lipomatous tumor with minimal nuclear atypia.
Storlazzi CT; Mertens F; Domanski H; Fletcher CD; Wiegant J; Mandahl N
Int J Oncol; 2003 Jul; 23(1):67-71. PubMed ID: 12792777
[TBL] [Abstract][Full Text] [Related]
35. The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma.
Limbach AL; Lingen MW; McElherne J; Mashek H; Fitzpatrick C; Hyjek E; Mostofi R; Cipriani NA
Head Neck Pathol; 2020 Dec; 14(4):889-898. PubMed ID: 32026294
[TBL] [Abstract][Full Text] [Related]
36. Clinical outcome of low-grade central osteosarcoma and role of CDK4 and MDM2 immunohistochemistry as a diagnostic adjunct.
Jeon DG; Koh JS; Cho WH; Song WS; Kong CB; Cho SH; Lee SY; Lee SY
J Orthop Sci; 2015 May; 20(3):529-37. PubMed ID: 25740728
[TBL] [Abstract][Full Text] [Related]
37. Giant cell rich osteosarcoma revisited-diagnostic criteria and histopathologic patterns, Ki67, CDK4, and MDM2 expression, changes in response to bisphosphonate and denosumab treatment.
Chow LT
Virchows Arch; 2016 Jun; 468(6):741-55. PubMed ID: 27003154
[TBL] [Abstract][Full Text] [Related]
38. Monoallelic deletion of the p53 gene through chromosomal translocation in a small cell osteosarcoma.
Nishio J; Gentry JD; Neff JR; Nelson M; Daniels W; Perry D; Gatalica Z; Bridge JA
Virchows Arch; 2006 Jun; 448(6):852-6. PubMed ID: 16596382
[TBL] [Abstract][Full Text] [Related]
39. [Detection of MDM2 gene amplification by fluorescence in situ hybridization and its diagnostic value in low-grade osteosarcoma].
Li L; Zhang M; Dong RF; Su YB; Ding Y
Zhonghua Bing Li Xue Za Zhi; 2024 Mar; 53(3):237-242. PubMed ID: 38433050
[No Abstract] [Full Text] [Related]
40. Genome-wide array comparative genomic hybridization analysis reveals distinct amplifications in osteosarcoma.
Man TK; Lu XY; Jaeweon K; Perlaky L; Harris CP; Shah S; Ladanyi M; Gorlick R; Lau CC; Rao PH
BMC Cancer; 2004 Aug; 4():45. PubMed ID: 15298715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
